Global Trust Asset Management, LLC Crispr Therapeutics Ag Transaction History
Global Trust Asset Management, LLC
- $257 Million
- Q4 2024
A detailed history of Global Trust Asset Management, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Global Trust Asset Management, LLC holds 200 shares of CRSP stock, worth $8,690. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200
Previous 500
60.0%
Holding current value
$8,690
Previous $23,000
69.57%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding CRSP
# of Institutions
487Shares Held
64.1MCall Options Held
1.64MPut Options Held
1.93M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.97MShares$390 Million3.09% of portfolio
-
Capital International Investors Los Angeles, CA8.74MShares$380 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.81MShares$166 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$121 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.75MShares$119 Million0.07% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.39B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....